Variant report
| Variant | rs1891312 |
|---|---|
| Chromosome Location | chr10:92618889-92618890 |
| allele | A/G |
| Outlinks | Ensembl UCSC |
| No. | Chromosome Location | Chromatin state | Cell line | Tissue |
|---|---|---|---|---|
| 1 | chr10:92614400-92619000 | Bivalent/Poised TSS | HUES6 Cell Line | embryonic stem cell |
| 2 | chr10:92614800-92619200 | Bivalent/Poised TSS | iPS-20b Cell Line | embryonic stem cell |
| 3 | chr10:92618000-92619000 | Flanking Active TSS | Muscle Satellite Cultured Cells | -- |
| 4 | chr10:92618000-92619000 | Flanking Active TSS | Foreskin Fibroblast Primary Cells skin01 | Skin |
| 5 | chr10:92618000-92619200 | Flanking Active TSS | Monocytes-CD14+_RO01746 | blood |
| 6 | chr10:92618000-92619400 | Flanking Active TSS | HMEC | breast |
| 7 | chr10:92618000-92619600 | Flanking Active TSS | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
| 8 | chr10:92618200-92619000 | Flanking Active TSS | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
| 9 | chr10:92618200-92619200 | Flanking Active TSS | Foreskin Keratinocyte Primary Cells skin02 | Skin |
| 10 | chr10:92618400-92619000 | Enhancers | NH-A | brain |
| 11 | chr10:92618400-92619200 | Enhancers | Primary T cells effector/memory enriched fromperipheralblood | blood |
| 12 | chr10:92618400-92619400 | Enhancers | A549 | lung |
| 13 | chr10:92618400-92619600 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
| 14 | chr10:92618400-92619600 | Enhancers | HSMM | muscle |
| 15 | chr10:92618400-92620000 | Enhancers | HUVEC | blood vessel |
| 16 | chr10:92618600-92619000 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
| 17 | chr10:92618600-92619000 | Enhancers | Osteobl | bone |
| 18 | chr10:92618600-92619200 | Bivalent Enhancer | iPS-18 Cell Line | embryonic stem cell |
| 19 | chr10:92618600-92619200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
| 20 | chr10:92618600-92619200 | Enhancers | Foreskin Fibroblast Primary Cells skin02 | Skin |
| 21 | chr10:92618600-92619600 | Enhancers | Primary monocytes fromperipheralblood | blood |
| 22 | chr10:92618600-92619800 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
| 23 | chr10:92618600-92619800 | Enhancers | NHDF-Ad | bronchial |
| 24 | chr10:92618600-92620000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
| 25 | chr10:92618600-92620200 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
| 26 | chr10:92618600-92621600 | Weak transcription | H1 Cell Line | embryonic stem cell |
| 27 | chr10:92618600-92621800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
| 28 | chr10:92618800-92619000 | Bivalent Enhancer | ES-I3 Cell Line | embryonic stem cell |
| 29 | chr10:92618800-92619000 | Flanking Active TSS | NHLF | lung |
| 30 | chr10:92618800-92619200 | Flanking Active TSS | Hela-S3 | cervix |
| 31 | chr10:92618800-92619200 | Flanking Active TSS | NHEK | skin |
